McKesson Corporation  

(Public, NYSE:MCK)   Watch this stock  
Find more results for mckesson
+1.46 (0.64%)
Apr 17 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 223.36 - 228.41
52 week 164.58 - 232.69
Open 225.15
Vol / Avg. 1.46M/926,949.00
Mkt cap 53.10B
P/E 30.76
Div/yield 0.24/0.42
EPS 7.41
Shares 232.84M
Beta 0.67
Inst. own 86%
May 11, 2015
Q4 2015 McKesson Corp Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Mar 3, 2015
McKesson Corp at Cowen Health Care Conference
Feb 5, 2015
Q3 2015 McKesson Corp Earnings Call
Feb 5, 2015
Q3 2015 McKesson Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 1.09% 0.98%
Operating margin 1.66% 1.72%
EBITD margin - 2.35%
Return on average assets 3.83% 3.13%
Return on average equity 21.11% 17.43%
Employees 42,800 -
CDP Score - -


United States - Map
+1-415-9838300 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia


McKesson Corporation delivers pharmaceuticals, medical supplies and healthcare information technology. The Company operates in two segments. The McKesson Distribution Solutions segment distributes ethical and drugs and equipment and health and beauty care products throughout North America and internationally. This segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The McKesson Technology Solutions segment includes McKesson Health Solutions, which includes the Company�s InterQual clinical criteria solution, claims payment solutions and network performance tools. This segment delivers enterprise-wide clinical, patient care, financial, supply chain, strategic management software solutions, as well as connectivity, outsourcing and other services.

Officers and directors

John Harvey Hammergren Chairman of the Board, President, Chief Executive Officer
Age: 56
Bio & Compensation  - Reuters
James A. Beer Chief Financial Officer, Executive Vice President
Age: 53
Bio & Compensation  - Reuters
Randall N. Spratt Chief Information Officer, Chief Technology Officer, Executive Vice President
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Lori A. Schechter Executive Vice President, Chief Compliance Officer, General Counsel
Bio & Compensation  - Reuters
Jorge L. Figueredo Executive Vice President - Human Resources
Age: 53
Bio & Compensation  - Reuters
Patrick J. Blake Executive Vice President, Group President
Age: 50
Bio & Compensation  - Reuters
Paul Coleman Julian Executive Vice President, Group President
Age: 60
Bio & Compensation  - Reuters
Bansi Nagji Executive Vice President - Corporate Strategy and Business Development
Bio & Compensation  - Reuters
Brian S. Tyler Ph.D. Executive Vice President - Corporate Strategy and Business Development
Age: 47
Bio & Compensation  - Reuters
Andrew D. Bryant Independent Director
Age: 64
Bio & Compensation  - Reuters